Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

The renin angiotensin system blockade in kidney transplantation: pros and cons.

Cruzado JM, Rico J, Grinyó JM.

Transpl Int. 2008 Apr;21(4):304-13. doi: 10.1111/j.1432-2277.2008.00638.x. Epub 2008 Feb 4. Review.

2.

Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.

Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF.

Nephrol Dial Transplant. 2004 Nov;19(11):2852-7. Epub 2004 Oct 5.

PMID:
15466882
3.

Is RAS blockade routinely indicated in hypertensive kidney transplant patients?

Salzberg DJ.

Curr Hypertens Rep. 2007 Nov;9(5):422-9. Review.

PMID:
18177591
4.

RAS blockade in experimental renal transplantation. Benefits and limitations.

Smit-van Oosten A, Stegeman CA, van Goor H.

Curr Drug Targets Cardiovasc Haematol Disord. 2003 Mar;3(1):73-9. Review.

PMID:
12769646
5.

Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.

Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E.

Am Heart J. 2008 May;155(5):791-805. doi: 10.1016/j.ahj.2008.01.031. Erratum in: Am Heart J. 2009 Mar;157(3):501. Jalandara, Nishant [corrected to Jalandhara, Nishant].

PMID:
18440325
6.

RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.

Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, Yusuf S, Böhm M.

Clin Res Cardiol. 2008 Jul;97(7):418-31. doi: 10.1007/s00392-008-0668-3. Epub 2008 May 3. Review.

PMID:
18454336
7.

Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.

Griffin KA, Bidani AK.

Clin J Am Soc Nephrol. 2006 Sep;1(5):1054-65. Epub 2006 Jul 12. Review.

8.

Routine renin-angiotensin system blockade in renal transplantation?

Remuzzi G, Perico N.

Curr Opin Nephrol Hypertens. 2002 Jan;11(1):1-10. Review.

PMID:
11753080
9.

Angiotensin receptor blockers: RAAS blockade and renoprotection.

Ruilope LM.

Curr Med Res Opin. 2008 May;24(5):1285-93. doi: 10.1185/030079908X291921 . Epub 2008 Mar 25. Review.

PMID:
18366863
10.

Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.

Yamada K, Hatakeyama E, Arita S, Sakamoto K, Kashiwabara H, Hamaguchi K.

Clin Exp Nephrol. 2003 Sep;7(3):238-42.

PMID:
14586721
11.

Inhibiting the renin-angiotensin system: why and in which patients.

Berra K, Miller NH.

J Am Acad Nurse Pract. 2009 Jan;21(1):66-75. doi: 10.1111/j.1745-7599.2008.00374.x. Review.

PMID:
19125897
12.

[Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].

Abassi Z, Armaly Z, Nakhoul F, Hoffman A.

Harefuah. 2008 Jun;147(6):536-42, 573. Review. Hebrew.

PMID:
18693632
13.

The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design.

Knoll GA, Cantarovitch M, Cole E, Gill J, Gourishankar S, Holland D, Kiberd B, Muirhead N, Prasad R, Tibbles LA, Treleaven D, Fergusson D.

Nephrol Dial Transplant. 2008 Jan;23(1):354-8. Epub 2007 Sep 10.

PMID:
17848393
14.

Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials.

Hiremath S, Fergusson DA, Fergusson N, Bennett A, Knoll GA.

Am J Kidney Dis. 2017 Jan;69(1):78-86. doi: 10.1053/j.ajkd.2016.08.018. Epub 2016 Oct 4. Review.

PMID:
27712852
15.

The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point.

Messerli FH.

J Am Coll Cardiol. 2009 Feb 10;53(6):468-70. doi: 10.1016/j.jacc.2008.10.036. Review.

16.

Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers.

Marathias KP, Agroyannis B, Mavromoustakos T, Matsoukas J, Vlahakos DV.

Curr Top Med Chem. 2004;4(4):483-6. Review.

PMID:
14965314
17.

Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation.

Morath C, Schmied B, Mehrabi A, Weitz J, Schmidt J, Werner J, Buchler MW, Morcos M, Nawroth PP, Schwenger V, Doehler B, Opelz G, Zeier M.

Clin Transplant. 2009 Dec;23 Suppl 21:33-6. doi: 10.1111/j.1399-0012.2009.01107.x. Review.

PMID:
19930314
18.

Blocking the renin-angiotensin system: dual- versus mono-therapy.

Ravandi A, Teo KK.

Expert Rev Cardiovasc Ther. 2009 Jun;7(6):667-74. doi: 10.1586/erc.09.47. Review.

PMID:
19505282
20.

Progression of chronic kidney disease: can it be prevented or arrested?

Jaber BL, Madias NE.

Am J Med. 2005 Dec;118(12):1323-30. Review.

PMID:
16378772

Supplemental Content

Support Center